Search research articles
Contact Us
Filters
Showing results (21-30 of 90) with videos related to
Page
of 9
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
September 13, 2003
Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma
Ioannis Ilias, Juan Yu, Jorge A Carrasquillo, et al.
Cancer Chemotherapy and Pharmacology
|
October 22, 2015
Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors
Elizabeth Fox, Brigitte C Widemann, Devang Pastakia, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 4, 2025
Prospective Evaluation of 68Ga-DOTATATE and 18F-DOPA PET Scans in Detecting Tumors Causing Ectopic ACTH Syndrome
Henrik Elenius, Raven McGlotten, Chuong D Hoang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
November 5, 2002
Role of preoperative localization and intraoperative localization maneuvers including intraoperative PTH assay determination for patients with persistent or recurrent hyperparathyroidism
H Richard Alexander, Clara C Chen, Thomas Shawker, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 12, 2015
18F-FLT PET/CT in the Evaluation of Pheochromocytomas and Paragangliomas: A Pilot Study
Elise M Blanchet, David Taieb, Corina Millo, et al.
Clinical Nuclear Medicine
|
February 2, 2016
Rapidly Growing Chest Wall Mass in a Case of Sporadic Metastatic Paraganglioma: Imaging With 4 Different PET Radiopharmaceuticals
Ingo Janssen, Paraskevi Xekouki, Joan Nambuba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2003
Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576
Manish Agrawal, Jame Abraham, Frank M Balis, et al.
Nuclear Medicine Communications
|
December 13, 2005
Discordant localization of 2-[18F]-fluoro-2-deoxy-D-glucose in 6-[18F]-fluorodopamine- and [(123)I]-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites
Marcelo Mamede, Jorge A Carrasquillo, Clara C Chen, et al.
BJU International
|
December 13, 2006
Routine interval computed tomography to detect new soft-tissue disease might be unnecessary in patients with androgen-independent prostate cancer and metastasis only to bone
Shenhong L Wu, Elizabeth Jones, James L Gulley, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 17, 2008
Comparison of 6-18F-fluorodopamine PET with 123I-metaiodobenzylguanidine and 111in-pentetreotide scintigraphy in localization of nonmetastatic and metastatic pheochromocytoma
Ioannis Ilias, Clara C Chen, Jorge A Carrasquillo, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 90) with videos related to
Sort By:
Page
of 9
The Journal of Clinical Endocrinology and Metabolism
|
September 13, 2003
Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma
Ioannis Ilias, Juan Yu, Jorge A Carrasquillo, et al.
Cancer Chemotherapy and Pharmacology
|
October 22, 2015
Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors
Elizabeth Fox, Brigitte C Widemann, Devang Pastakia, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 4, 2025
Prospective Evaluation of 68Ga-DOTATATE and 18F-DOPA PET Scans in Detecting Tumors Causing Ectopic ACTH Syndrome
Henrik Elenius, Raven McGlotten, Chuong D Hoang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
November 5, 2002
Role of preoperative localization and intraoperative localization maneuvers including intraoperative PTH assay determination for patients with persistent or recurrent hyperparathyroidism
H Richard Alexander, Clara C Chen, Thomas Shawker, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 12, 2015
18F-FLT PET/CT in the Evaluation of Pheochromocytomas and Paragangliomas: A Pilot Study
Elise M Blanchet, David Taieb, Corina Millo, et al.
Clinical Nuclear Medicine
|
February 2, 2016
Rapidly Growing Chest Wall Mass in a Case of Sporadic Metastatic Paraganglioma: Imaging With 4 Different PET Radiopharmaceuticals
Ingo Janssen, Paraskevi Xekouki, Joan Nambuba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2003
Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576
Manish Agrawal, Jame Abraham, Frank M Balis, et al.
Nuclear Medicine Communications
|
December 13, 2005
Discordant localization of 2-[18F]-fluoro-2-deoxy-D-glucose in 6-[18F]-fluorodopamine- and [(123)I]-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites
Marcelo Mamede, Jorge A Carrasquillo, Clara C Chen, et al.
BJU International
|
December 13, 2006
Routine interval computed tomography to detect new soft-tissue disease might be unnecessary in patients with androgen-independent prostate cancer and metastasis only to bone
Shenhong L Wu, Elizabeth Jones, James L Gulley, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 17, 2008
Comparison of 6-18F-fluorodopamine PET with 123I-metaiodobenzylguanidine and 111in-pentetreotide scintigraphy in localization of nonmetastatic and metastatic pheochromocytoma
Ioannis Ilias, Clara C Chen, Jorge A Carrasquillo, et al.
Page
of 9